Urologix (ULGX) Names Fluet Interim CEO, Replacing Retiring Warren  
11/21/2012 9:24:34 AM

Greg Fluet has been named interim CEO of Urologix Inc., replacing Stryker Warren Jr., who is retiring at the end of the month. Fluet has been chief operating officer of Plymouth-based Urologix (Nasdaq: ULGX), which develops technology for treating urological disorders, since July 2008. Before joining Urologix, Fluet worked at Sapient Capital Management, a Wyoming-based venture capital firm focused on medical devices.